Articles tagged "Cytomeglovirus"

2021 American Transplant Congress
Real-world Treatment Patterns of Antiviral Agents for Cytomegalovirus Among Adult Kidney Transplant Recipients: A USRDS-Medicare Linked Database Study
A. D. Raval¹, M. Ganz², P. Saravanan², Y. Tang¹, C. A. Santos³
¹Merck & Co., Inc., Kenilworth, NJ, ²Evidera, Inc., Waltham, MA, ³Rush University Medical Center, Chicago, IL
*Purpose: Cytomegalovirus (CMV) is a common viral pathogen among kidney transplant recipients (KTRs). Although guidelines recommend the use of prophylaxis or pre-emptive antiviral (AV) therapy…
2021 American Transplant Congress
Impact of Valganciclovir Prophylaxis Dosing in High Risk Cytomegalovirus Kidney and Pancreas Transplant Recipients with Delayed Graft Function
A. Gharabagi¹, J. Geyston¹, A. Agarwal², S. Rao³, A. Doyle³, J. Dann¹
¹Pharmacy, University of Virginia Health System, Charlottesville, VA, ²Transplant Surgery, University of Virginia Health System, Charlottesville, VA, ³Transplant Nephrology, University of Virginia Health System, Charlottesville, VA
*Purpose: We sought to compare outcomes of cytomegalovirus (CMV) prophylaxis in high risk CMV (donor +/recipient -) kidney and pancreas transplant recipients who received different…
2021 American Transplant Congress
Cytomegalovirus Infection Among Adult Kidney Transplant Recipients: Findings From the USRDS-medicare Linked Database Study
A. Raval¹, M. Ganz², S. Alam², Y. Tang¹, C. Santos³
¹Merck & Co., Inc., Rahway, NJ, ²Evidera-PPD, Waltham, MA, ³Rush University Medical Center, Chicago, IL
*Purpose: Cytomegalovirus infection (CMVi) is a frequent complication and significant cause of morbidity and mortality after kidney transplantation (KT). However, there are limited recent national…
2021 American Transplant Congress
Breakthrough Cytomegalovirus DNAemia in High vs Intermediate Risk Heart Transplant Recipients
G. Huang¹, O. E. Beaird¹, M. Davis², M. Carlson¹, S. Chang¹, P. Gaynor¹, A. Fan², M. Deng³, A. Multani¹, A. Nsair³, J. Schaenman¹
¹Infectious Diseases, UCLA, Los Angeles, CA, ²Pharmacy, UCLA, Los Angeles, CA, ³Cardiology, UCLA, Los Angeles, CA
*Purpose: Cytomegalovirus (CMV) is one of the most common infections after transplantation and continues to cause significant morbidity and mortality despite prophylaxis and screening strategies.…
2021 American Transplant Congress
Impact of Cytomegalovirus Prophylaxis on Herpes Simplex and Varicella Zoster Virus Infections in Kidney Transplant Recipients
K. Ridgely¹, B. Crowther², P. Klem², K. Schoeppler¹, K. Schwarz¹, A. Nadrash², V. Lewis¹, E. Benamu³
¹Department of Pharmacy Services, UCHealth University of Colorado Hospital, Aurora, CO, ²Ambulatory Care Pharmacy Services, UCHealth University of Colorado Hospital, Aurora, CO, ³Department of Medicine, UCHealth University of Colorado Hospital, Aurora, CO
*Purpose: To assess the impact of cytomegalovirus (CMV) targeted antiviral prophylaxis on the development of herpes simplex (HSV) and varicella zoster (VZV) infections after kidney…
2021 American Transplant Congress
Evaluation of High-versus Low-Dose Valganciclovir for Cytomegalovirus Prevention in Adult Liver Transplant Recipients: A Single Center Experience
P. Parikh¹, M. Siddiqui², O. De La Cruz², G. Gupta², D. Kumar², I. Yakubu²
¹Our Lady of the Lake Regional Medical Center, Baton Rouge, LA, ²Virginia Commonwealth University Health System, Richmond, VA
*Purpose: Cytomegalovirus (CMV) is the most common infection after solid organ transplantation and is associated with increased morbidity and mortality. CMV prophylaxis is widely considered…
2021 American Transplant Congress
Significance of Detectable but Unquantifiable Viremias Post Renal Transplantation
M. Chaung, S. Puri, S. Bunin, Z. Mondal, O. Eletta, R. Pelletier, A. Bongu
Robert Wood Johnson University Hospital, New Brunswick, NJ
*Purpose: It is unknown whether the degree of the initial viremia following kidney (KT) or combined kidney-pancreas transplantation (SPKT) correlates with future allograft rejection or…
2021 American Transplant Congress
Pregnancy After CMV Infection Following Uterus Transplantation: A Case Report
M. Rosenzweig, A. Wall, G. Testa, L. Johannesson
Abdominal Transplant Surgery, Baylor University Medical Center, Dallas, TX
*Purpose: Uterus transplantation (UTx) is a repeatedly proven treatment for women with absolute uterine factor infertility who wish to carry a pregnancy. One aspect of…
2021 American Transplant Congress
Simulation Model for Cytomegalovirus Matching in Deceased Donor Kidney Allocation System in the U.S.
B. Tanriover¹, V. K. Ariyamuthu¹, T. Zangeneh², M. M. Al Obaidi², Y. Ulukus³, M. A. Ergun³, B. Sandikci⁴
¹Department of Medicine / Nephrology, University of Arizona, COM Tucson, Tucson, AZ, ²Department of Medicine / Infectious Disease, University of Arizona, COM Tucson, Tucson, AZ, ³Operations Management, Istanbul Technical University, Istanbul, Turkey, ⁴Operations Management, University of Chicago, Chicago, IL
*Purpose: The prevalence of positive and negative cytomegalovirus (CMV) serology among transplant recipients and donors are approximately 60-65% and 30-35%, respectively. CMV mismatch, donor-positive/recipient-negative status…
2021 American Transplant Congress
Cytomegalovirus Nephritis: Epidemiology and Outcomes of an Uncommon Diagnosis
K. J. Swanson, A. Djamali, A. Ghaffar, F. Aziz, N. Garg, M. Mohamed, D. A. Mandelbrot, M. Jorgensen, S. Parajuli
Division of Nephrology, University of Wisconsin-Madison, Madison, WI
*Purpose: Cytomegalovirus (CMV) nephritis is an uncommon end-organ manifestation of CMV disease. Due to this, associated outcomes have not been completely elucidated.*Methods: This was a…

« Previous Page
1
…
3
4
5
6
7
…
33
Next Page »